Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H17N5O2 |
| Molecular Weight | 347.3706 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)NC1=CC=C(C=C1)C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(N)=N
InChI
InChIKey=MQQNFDZXWVTQEH-UHFFFAOYSA-N
InChI=1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24)
| Molecular Formula | C19H17N5O2 |
| Molecular Weight | 347.3706 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:52:03 UTC 2023
by
admin
on
Fri Dec 15 15:52:03 UTC 2023
|
| Record UNII |
Y25LQ0H97D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
835721
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
||
|
NCI_THESAURUS |
C783
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
742120
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL273264
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
DTXSID0048420
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
4413
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
DB12598
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
SUB09114MIG
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
100000091465
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
Y25LQ0H97D
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
81525-10-2
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
1867
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
m7704
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | Merck Index | ||
|
NAFAMOSTAT
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
4262
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
5682
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
C032855
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY | |||
|
C96292
Created by
admin on Fri Dec 15 15:52:03 UTC 2023 , Edited by admin on Fri Dec 15 15:52:03 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
Inhibits a large number of Lys/Arg specific serine proteinases.
IC50
|
||
|
TARGET -> INHIBITOR |
May block Sars-CoV-2 infection inhibiting spike protein infectivity.
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
